Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at cisplatin and irinotecan for advanced pancreatic cancer (PAIR)

Overview

Cancer types:

Pancreatic cancer

Status:

Results

Phase:

Phase 2

Details

This trial looked at a new combination of chemotherapy with cisplatin and irinotecan for people with advanced pancreatic cancer.

It recruited people who hadn’t had treatment for their cancer before.

Recruitment start: 1 January 2000

Recruitment end: 1 January 2002

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Bass Hassan

Supported by

Aventis Pharma

Queen Elizabeth Hospital Birmingham

University of Birmingham

Last reviewed: 23 Nov 2015

CRUK internal database number: 195

Help and support